The acute myeloid leukemias are genetically a diverse group of neoplasm with varied clinical behavior and response to treatment. Advances in immunophenotyping. cytogenetics and molecular genetics have resulted in better understanding of their genesis. Risk stratification of different variants is now emerging. https://www.socialstudiesscholar.com/